September 2025 FDA Recall Succinylcholine by Dr. Reddy's Laboratories, Inc. (D-0008-2026 - Out-of-Specification (OOS) result during the 6-month stability testing; decreased preservative concentration.)

This Class II drug recall was voluntarily initiated by Dr. Reddy's Laboratories, Inc. on September 26, 2025 for the product Succinylcholine. The FDA reported the reason for recall as out-of-specification (oos) result during the 6-month stability testing; decreased preservative concentration.. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0008-2026

Reason for Recall
Out-of-Specification (OOS) result during the 6-month stability testing; decreased preservative concentration.
Initiated
09-26-2025
Reported
10-15-2025
Quantity
571 vials

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Dr. Reddy's Laboratories, Inc.
Nationwide within the USA.
Succinylcholine Chloride Injection, USP, 200 mg/10 mL (20 mg/mL), 25 x 10 mL Multiple-Dose Vials, For Intravenous or Intramuscular use, Rx Only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540. NDC: 43598-666-25

Batch or Lot Expiration Information

Lot# K250048

Affected Packages Involved in this Recall